ZeroStack (ZSTK) director receives 28,000 stock options at $5.10
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
ZeroStack Corp. director Laurence Zeifman reported a compensation-related award of options to buy 28,000 Common Shares. These director stock options have an exercise price of $5.10 per share and were granted at no cost.
The options vest in three equal installments: one-third on May 5, 2026, one-third on August 30, 2026, and one-third on December 31, 2026. Following this award, Zeifman holds 28,000 director stock options directly, with an expiration date of May 4, 2036.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Zeifman Laurence
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Director Stock Option ("Right to Buy") | 28,000 | $0.00 | -- |
Holdings After Transaction:
Director Stock Option ("Right to Buy") — 28,000 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Options granted: 28,000 options
Exercise price: $5.10 per share
Expiration date: May 4, 2036
+1 more
4 metrics
Options granted
28,000 options
Director stock option grant on May 5, 2026
Exercise price
$5.10 per share
Exercise price for director stock options
Expiration date
May 4, 2036
Option term for director grant
Post-grant option holdings
28,000 options
Total derivative holdings following transaction
Key Terms
Director Stock Option, Grant, award, or other acquisition, exercise price, vest
4 terms
Director Stock Option financial
"security_title: "Director Stock Option ("Right to Buy")""
Grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
exercise price financial
"conversion_or_exercise_price: "5.1000""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest financial
"The options vest as follows: 1/3 on May 5, 2026; 1/3 on August 30, 2026; and 1/3 on December 31, 2026."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
FAQ
What did Laurence Zeifman report in this ZeroStack Corp. (ZSTK) Form 4?
Laurence Zeifman reported receiving a grant of director stock options for 28,000 Common Shares of ZeroStack Corp. This is a compensation-related award, not an open-market trade, and reflects options rather than immediate ownership of common shares.
What is the exercise price and term of Zeifman’s ZeroStack (ZSTK) options?
The options have an exercise price of $5.10 per share and expire on May 4, 2036. This means Zeifman can choose to buy ZeroStack common shares at $5.10 up until that expiration date, subject to the vesting schedule.
What is the vesting schedule for Laurence Zeifman’s ZeroStack (ZSTK) option grant?
The options vest in three equal tranches: 1/3 on May 5, 2026, 1/3 on August 30, 2026, and 1/3 on December 31, 2026. Vesting means those portions become exercisable on the respective dates.
Does this ZeroStack (ZSTK) Form 4 show any stock sales or purchases by Zeifman?
No stock sales or open-market purchases are reported. The Form 4 shows a grant/award acquisition of stock options, a compensation event, with no buy or sell transactions in common shares disclosed in this filing.
What are Zeifman’s reported holdings after this ZeroStack (ZSTK) option grant?
After the grant, the filing shows Zeifman directly holding 28,000 director stock options linked to an equal number of underlying common shares. No additional derivative positions are listed in the remaining-derivatives section of this Form 4.